Diaceutics Regulatory News (DXRX)

Name of applicant:

Diaceutics PLC

Name of scheme:

UK and Global Share Incentive Plan for employees (the "SIP") and the Employee Share Option Plan (the "ESOP") which includes long-term incentive awards.

Period of return:

From:

7 October 2024

To:

6 April 2025

Balance under scheme from previous return:

1,423,411 Ordinary Shares of £0.002 each

The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:

N/A

Number of securities issued/allotted under schemes during period:

71,443 Ordinary Shares

Balance under scheme not yet issued/allotted at end of period

1,351,968 Ordinary Shares

Number and class of securities originally listed and the date of admission

1,500,000 Ordinary Shares on 6 October 2023

Total number of securities in issue at the end of the period

84,798,378 Ordinary Shares of £0.002 each

Name of contact:

Nick Roberts

Telephone number of contact:

As below

Diaceutics PLC 

Ryan Keeling, Chief Executive Officer  

Nick Roberts, Chief Financial Officer 

Tel: +44 (0)28 9040 6500

investorrelations@diaceutics.com

Canaccord Genuity Limited (Nomad & Broker) 

Tel: +44 (0)20 7523 8000

Simon Bridges, Andrew Potts, Harry Rees